I only have 400 shares left. That will only gain me $4000 at 20 pps. I think I'll just donate that to charity.
Congratulations to those who held onto their shares.
The plan was for me to dump all my losing shares by end of May before the announcement in June and leave only my 2.5 and 5 July calls to play it safe. Best laid out plan ruined by management. GRRR!
Can't really blame the longs in this board. We were all misled by the impressive Ph1 results. It looks like even Pfizer, who was privy to the details of the studies, was misled.
Good you were able to sell. I was waiting for the upward push before the news. Mgmt is clueless, and so am I. I should have stuck with ADXS!
Yes, the non-responders responded somehow. Either the doctors who administered the VEGF before the trials used fake avastin from an internet pharmacy, or the patients just haven't gotten enough doses yet to demonstrate improvement. LPath was in a hurry to complete recruitment that they got ineligible patients and bad trial results in the end.
Nasdaq. BB new holdings = 999,496 shares of IMGN.
BB in SGEN and IMGN says that ADCs are here to stay with CAR-Ts and chkpt inhibitors.
IMGN - Baker Bros finally started a position. Low pps for a company with at least some steady income, and somewhat proven technology platform. Mgmt is not the best though.
Now 53% ORR is better than the initial 40% reported in the article.
I wonder if they can find a company to buy rights to SAR3419, or partner. Spectrum maybe interested.
Probably will qualify for breakthrough.
With the impressive results for CAR-Ts for CD19, I think 3419 may be dead. Looks like CAR-Ts now are favored for liquid tumors, but they don't seem to work as well in solid tumors. Maybe combining Kadcyla with Halozyme's hyaluronidase will yield better results.
Cheater Cohen should be rotting in prison with Raj, and all their ill-gotten wealth returned to small time investors like me!
Sorry, Mabman. That's a lot of dough compared to my gambling money!
I added more when I learned about the BB buy. I figure with all the partnerships and gastric promise, 9 is simply too low.